Baldry Mark
SEC CIK 1644137 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals, Inc | Chief Commercial Off | 25.3K | $21.8K | $27.1K | 10 | 2023-10-31 | 2025-05-16 |
Most active insiders at XFOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Craig Adam R | Executive COB, Dir | $250.0K | $210.8K |
| 2 | KIRSKE DAVID | CFO | — | $109.2K |
| 3 | Volpone John | Pres | — | $109.2K |
Baldry Mark made no open-market trades at XFOR in the last 12 months.
Transactions 10
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2025-06-03 | 2025-05-16 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | A - Grant | $2.48 | +1,032 | 25.3K | +4% | +$2,559 |
| 2025-05-20 | 2025-05-16 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | P - Purchase | $2.48 | +1,032 | 25.3K | +4% | +$2,559 | |
| M | 2025-02-14 | 2024-05-17+ | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | P - Purchase | $0.55 | +35.0K | 129.2K | +37% | +$19.3K |
| 2025-02-14 | 2025-02-12 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | A - Grant | $0.00 | +600.0K | 729.2K | +464% | $0 | |
| 2025-01-27 | 2025-01-23 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | A - Grant | $0.00 | +74.8K | 123.3K | +154% | $0 | |
| 2025-01-27 | 2025-01-24 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | S - Sale | $0.45 | -29.2K | 94.1K | -24% | -$13.1K | |
| 2024-10-08 | 2024-10-07 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | S - Sale | $0.58 | -11.1K | 48.5K | -19% | -$6,454 | |
| 2024-10-08 | 2024-10-04 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | A - Grant | $0.00 | +34.9K | 59.6K | +142% | $0 | |
| 2023-11-03 | 2023-11-01 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | S - Sale | $0.73 | -10.3K | 24.7K | -29% | -$7,488 | |
| 2023-11-02 | 2023-10-31 | XFOR | X4 Pharmaceuticals, Inc | Baldry Mark | Chief Commercial Off | A - Grant | $0.00 | +34.9K | 34.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations